Ooft"When the company stepped up to the fourth dose, they quickly ran into problems as grade 3 and 4 SAEs were observed in patients who received the higher dose of 0.13 mg/kg. This led the trial to drop back down to the third dose level.However, this de-escalation has failed to tame the safety problems as the most recent patient given a dose of 0.08 mg/kg experienced respiratory failure and cardiac arrest, possibly related to MGTA-117, which led to death."
Thankful we have a good understanding Zantrenes safety profile already
Industry news, page-973
-
- There are more pages in this discussion • 753 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |